CMBN presented extensively on International Business Times web site
The Norwegian Centre for Molecular Biology and Neuroscience (CMBN) at the Oslo University Hospital and University of Oslo (UiO) was among the initial 13 Norwegian Centres of Excellence (SFF) established. After ten years, its activities as an SFF centre are drawing to a close. In connection with this, the centre has been extensively presented in an article published in the "Business and Health" section of the major online global newspaper "International Business Times", under the headline "Important brain discoveries". It is here pointed out that the centre's interdisciplinary research on DNA repair mechanisms in the brain is at the very forefront of the field.
From major journals, first or last author from the Institute for Cancer Research
Hauge A, Gaustad JV, Huang R, Simonsen TG, Wegner CS, Andersen LMK, Rofstad EK(2019) DCE-MRI and Quantitative Histology Reveal Enhanced Vessel Maturation but Impaired Perfusion and Increased Hypoxia in Bevacizumab-Treated Cervical Carcinoma Int J Radiat Oncol Biol Phys(in press) DOI 10.1016/j.ijrobp.2019.03.002, PubMed 30858145
Ã–jlert Ã…K, Halvorsen AR, Nebdal D, Lund-Iversen M, Solberg S, Brustugun OT, Lingjaerde OC, Helland Ã…(2019) The immune microenvironment in non-small cell lung cancer is predictive of prognosis after surgery Mol Oncol(in press) DOI 10.1002/1878-0261.12475, PubMed 30854794
Steen CB, Leich E, Myklebust JH, Lockmer S, Wise JF, Wahlin BE, Ã˜stenstad B, LiestÃ¸l K, Kimby E, Rosenwald A, Smeland EB, Holte H, LingjÃ¦rde OC, Brodtkorb M(2019) A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy Haematologica(in press) DOI 10.3324/haematol.2018.209080, PubMed 30846496